Clinical Trial Update: A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor [Phase 1]

View source ↗

Summary

Phase I clinical trial update for BPI-16350 in patients with advanced solid tumors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• BPI-16350 (BPI-16350)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Advanced Solid Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING